What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users

Diabetes Technology and Therapeutics

Volumn 15, Issue 4, 2013, Pages 295-301

  Polonsky, William H ^a,b   Hessler, Danielle ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Behavioral Diabetes Institute   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REAL TIME CONTINUOUS GLUCOSE MONITORING;

EID: 84876155919     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0298     Document Type: Article

References (19)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1381.
3. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Group: Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Trial. Diabetes Care 2010;33:17-22.
4. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Group: Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther 2010;12:679-684.
6. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Group: Satisfaction with continuous glucose monitoring in adults and youths with type 1 diabetes. Diabet Med 2011;28:1118-1122.
7. Halford J, Harris C: Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy. Diabetes Technol Ther 2010;12:201-205.
8. Ramchandani N, Arya S, Ten S, Bhandari S: Real-life utilization of real-time continuous glucose monitoring: The complete picture. J Diabetes Sci Technol 2011;5:860-870.
9. Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ: Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev 2012;(1):CD008101.
10. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J: Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time? Diabetes Technol Ther 2009;11:11-18.
11. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb P: Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther 2009;11:65-72.
12. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA: Assessing psychosocial distress in diabetes: Development of the Diabetes Distress Scale. Diabetes Care 2005;28:626-631.
13. Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, Cox DJ: Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes. Diabetes Care 2011;34:801-806.
14. Ritholz MD, Atakov-Castillo A, Beste M, Beverly EA, Leighton A, Weinger K, Wolpert H: Psychosocial factors associated with use of continuous glucose monitoring. Diabet Med 2010;27:1060-1065.
15. Schmidt S, Duun-Henriksen AK, Nørgaard K: Psychosocial factors and adherence to continuous glucose monitoring in type 1 diabetes. J Diabetes Sci Technol 2012;6:986-987.
16. Garg SK, Voelmle MK, Beatson CR, Miller HA, Crew LB, Freson BJ, Hazenfield RM: Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: A prospective 6-month study. Diabetes Care 2011;34:574-579.
17. Rodbard D, Jovanovic L, Garg SK: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther 2009;11:757-765.
18. Evaluation of Quality of Life and Costs in Diabetes Type 1 (EQuality1) Study Group: Quality of life and treatment satisfaction in adults with type 1 diabetes: A comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008;25:213-220.
19. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM: Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38.